AI Precision Communication in P… Pharmaceutical communication is entering an “attention economy” where access is not earned by frequency, but by relevance. The legacy commercial model—built on share of voice and prescription-volume segmentation—assumed that more touchpoints would translate into more impact. That assumption is now structurally unstable, because modern clinicians filter out low-utility signals and […]